« More notes on Pfizer's Bayesian model | Main | Pfizer modeling in Python »


Feed You can follow this conversation by subscribing to the comment feed for this post.

Michael Droy

We can debate whether Covid 19 is 1 or 2 or 3 times as dangerous as Flu.
But a vaccine is not a big deal in terms of saving lives, unlike say getting hospitals to do as many early cancer tests as before.
What is it essential for is for allowing Governments to walk back all the daft and damaging restrictions of the past year and getting Economies back to normal and getting lifestyles back to normal.

It is the excuse Governments (and media) need to undo all that damage without having to say Sorry.


The difference between the vaccine and placebo is so great that the p value is going to be very small, whether they include or exclude some patients. The standard analysis in a clinical trial is intention to treat, so AstraZeneca should be analysing as randomised. It seems that it will be very difficult to determine any difference between the vaccines, with usage coming down to cost, side effects, delivery costs and availability.


Ken: I have not checked the AstraZeneca protocol but the Moderna protocol specifically stated that the per-protocol analysis is considered primary, and the ITT analysis is check off the list. The language of the Pfizer protocol is less clear but I believe they also will primarily use per-protocol. Analyzing as random is a good thing but not as good when it is known that errors have affected the treatment dosage on a subset of the participants. Exclusions are important to look at because the numbers here are such that the difference between stopping for efficacy and stopping for failure is about 10 cases. Unfortunately, outsiders will probably not know whether any of the exclusions are infections. I hope they report whether anyone got infected between doses because those are excluded from the second dose.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)

Kaiser Fung. Business analytics and data visualization expert. Author and Speaker.
Visit my website. Follow my Twitter. See my articles at Daily Beast, 538, HBR, Wired.

See my Youtube and Flickr.
Numbers Rule Your World:
Amazon - Barnes&Noble

Amazon - Barnes&Noble


  • only in Big Data

Next Events

Jan: 10 NYPL Data Science Careers Talk, New York, NY

Past Events

Aug: 15 NYPL Analytics Resume Review Workshop, New York, NY

Apr: 2 Data Visualization Seminar, Pasadena, CA

Mar: 30 ASA DataFest, New York, NY

See more here


R Fundamentals, Principal Analytics Prep

Numbersense: Statistical Reasoning in Practice, Principal Analytics Prep

Applied Analytics Frameworks & Methods, Columbia

The Art of Data Visualization, NYU

Signed copies at McNally-Jackson, NYC

Excerpts: Numbersense Ch. 1, 7, 8. NRYW

Junk Charts Blog

Link to junkcharts

Graphics design by Amanda Lee